3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
76
Active not recruiting
45
Completed
26
Not yet recruiting
24
Terminated
8
Enrolling by invitation
4
Suspended
3
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
10
Prostatic Neoplasms
7
Lung Neoplasms
6
Recurrence
4
Multiple Myeloma
4
Lymphoma, B-Cell
4
Lymphoma
4
Colorectal Neoplasms
4
Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Urologic Neoplasms
2
Solid Tumor
2
Small Cell Lung Carcinoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Glioblastoma
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Vasculitis
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
bemarituzumab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Uterine Cervical Neoplasms
×
90 days
×
Clear all
NCT07146919
2026-04-23
ANGELICA
Centre Leon Berard
Phase 1/2
Withdrawn